Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skipping Mutation

Clinical trial NCT05435846 · TERMINATED

Trial details

NCT number: NCT05435846
Sponsor: Collin Blakely
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Lung Non-Small Cell Carcinoma Stage IV Lung Cancer

Start date: 2022-08-10
Primary completion: 2023-11-30
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.